OBJECTIVE: The purpose of this study was to identify the pressure threshold for the destruction of Optison (octafluoropropane contrast agent; Amersham Health, Princeton, NJ) using a laboratory-assembled 3.5-MHz pulsed ultrasound system and a clinical diagnostic ultrasound scanner. METHODS: A 3.5-MHz focused transducer and a linear array with a center frequency of 6.9 MHz were positioned confocally and at 90 degrees to each other in a tank of deionized water. Suspensions of Optison (5-8x10(4) microbubbles/mL) were insonated with 2-cycle pulses from the 3.5-MHz transducer (peak rarefactional pressure, or Pr, from 0.0, or inactive, to 0.6 MPa) while being interrogated with fundamental B-mode imaging pulses (mechanical index, or MI,=0.04). Scattering received by the 3.5-MHz transducer or the linear array was quantified as mean backscattered intensity or mean digital intensity, respectively, and fit with exponential decay functions (Ae-kt+N, where A+N was the amplitude at time 0; N, background echogenicity; and k, decay constant). By analyzing the decay constants statistically, a pressure threshold for Optison destruction due to acoustically driven diffusion was identified. RESULTS: The decay constants determined from quantified 3.5-MHz radio frequency data and B-mode images were in good agreement. The peak rarefactional pressure threshold for Optison destruction due to acoustically driven diffusion at 3.5 MHz was 0.15 MPa (MI=0.08). Furthermore, the rate of Optison destruction increased with increasing 3.5-MHz exposure pressure output. CONCLUSIONS: Optison destruction was quantified with a laboratory-assembled 3.5-MHz ultrasound system and a clinical diagnostic ultrasound scanner. The pressure threshold for acoustically driven diffusion was identified, and 3 distinct mechanisms of ultrasound contrast agent destruction were observed with acoustic techniques.
OBJECTIVE: The purpose of this study was to identify the pressure threshold for the destruction of Optison (octafluoropropane contrast agent; Amersham Health, Princeton, NJ) using a laboratory-assembled 3.5-MHz pulsed ultrasound system and a clinical diagnostic ultrasound scanner. METHODS: A 3.5-MHz focused transducer and a linear array with a center frequency of 6.9 MHz were positioned confocally and at 90 degrees to each other in a tank of deionized water. Suspensions of Optison (5-8x10(4) microbubbles/mL) were insonated with 2-cycle pulses from the 3.5-MHz transducer (peak rarefactional pressure, or Pr, from 0.0, or inactive, to 0.6 MPa) while being interrogated with fundamental B-mode imaging pulses (mechanical index, or MI,=0.04). Scattering received by the 3.5-MHz transducer or the linear array was quantified as mean backscattered intensity or mean digital intensity, respectively, and fit with exponential decay functions (Ae-kt+N, where A+N was the amplitude at time 0; N, background echogenicity; and k, decay constant). By analyzing the decay constants statistically, a pressure threshold for Optison destruction due to acoustically driven diffusion was identified. RESULTS: The decay constants determined from quantified 3.5-MHz radio frequency data and B-mode images were in good agreement. The peak rarefactional pressure threshold for Optison destruction due to acoustically driven diffusion at 3.5 MHz was 0.15 MPa (MI=0.08). Furthermore, the rate of Optison destruction increased with increasing 3.5-MHz exposure pressure output. CONCLUSIONS: Optison destruction was quantified with a laboratory-assembled 3.5-MHz ultrasound system and a clinical diagnostic ultrasound scanner. The pressure threshold for acoustically driven diffusion was identified, and 3 distinct mechanisms of ultrasound contrast agent destruction were observed with acoustic techniques.
Authors: Constantin-C Coussios; Christy K Holland; Ludwika Jakubowska; Shao-Ling Huang; Robert C MacDonald; Ashwin Nagaraj; David D McPherson Journal: Ultrasound Med Biol Date: 2004-02 Impact factor: 2.998
Authors: P A Dayton; K E Morgan; A L Klibanov; G H Brandenburger; K W Ferrara Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 1999 Impact factor: 2.725
Authors: Susan T Laing; Hyunggun Kim; Jonathan A Kopechek; Devang Parikh; Shaoling Huang; Melvin E Klegerman; Christy K Holland; David D McPherson Journal: J Liposome Res Date: 2010-06 Impact factor: 3.648
Authors: Jason L Raymond; Ying Luan; Tao Peng; Shao-Ling Huang; David D McPherson; Michel Versluis; Nico de Jong; Christy K Holland Journal: Phys Med Biol Date: 2016-11-03 Impact factor: 3.609
Authors: Kirthi Radhakrishnan; Kenneth B Bader; Kevin J Haworth; Jonathan A Kopechek; Jason L Raymond; Shao-Ling Huang; David D McPherson; Christy K Holland Journal: Phys Med Biol Date: 2013-09-04 Impact factor: 3.609
Authors: Kirthi Radhakrishnan; Kevin J Haworth; Tao Peng; David D McPherson; Christy K Holland Journal: Ultrasound Med Biol Date: 2014-11-15 Impact factor: 2.998
Authors: Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland Journal: Ultrasound Med Biol Date: 2010-01 Impact factor: 2.998